AU2009217278B2 - Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism - Google Patents
Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism Download PDFInfo
- Publication number
- AU2009217278B2 AU2009217278B2 AU2009217278A AU2009217278A AU2009217278B2 AU 2009217278 B2 AU2009217278 B2 AU 2009217278B2 AU 2009217278 A AU2009217278 A AU 2009217278A AU 2009217278 A AU2009217278 A AU 2009217278A AU 2009217278 B2 AU2009217278 B2 AU 2009217278B2
- Authority
- AU
- Australia
- Prior art keywords
- autism
- chromosome
- nucleic acid
- cnv
- snp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 91
- 208000020706 Autistic disease Diseases 0.000 title claims description 180
- 206010003805 Autism Diseases 0.000 title claims description 179
- 230000004077 genetic alteration Effects 0.000 title claims description 20
- 231100000118 genetic alteration Toxicity 0.000 title claims description 20
- 238000011282 treatment Methods 0.000 title abstract description 11
- 238000003745 diagnosis Methods 0.000 title description 11
- 208000029560 autism spectrum disease Diseases 0.000 claims abstract description 98
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 150000007523 nucleic acids Chemical class 0.000 claims description 105
- 102000039446 nucleic acids Human genes 0.000 claims description 97
- 108020004707 nucleic acids Proteins 0.000 claims description 97
- 210000000349 chromosome Anatomy 0.000 claims description 72
- 210000004027 cell Anatomy 0.000 claims description 70
- 238000004458 analytical method Methods 0.000 claims description 52
- 230000002068 genetic effect Effects 0.000 claims description 49
- 239000000523 sample Substances 0.000 claims description 38
- 108700028369 Alleles Proteins 0.000 claims description 25
- 239000002773 nucleotide Substances 0.000 claims description 24
- 125000003729 nucleotide group Chemical group 0.000 claims description 24
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 claims description 23
- 238000009396 hybridization Methods 0.000 claims description 19
- 238000012217 deletion Methods 0.000 claims description 17
- 230000037430 deletion Effects 0.000 claims description 17
- 108091033319 polynucleotide Proteins 0.000 claims description 13
- 102000040430 polynucleotide Human genes 0.000 claims description 13
- 239000002157 polynucleotide Substances 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 229920002477 rna polymer Polymers 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 description 113
- 108020004414 DNA Proteins 0.000 description 40
- 108090000765 processed proteins & peptides Proteins 0.000 description 38
- 230000014509 gene expression Effects 0.000 description 37
- 238000003908 quality control method Methods 0.000 description 31
- 238000012098 association analyses Methods 0.000 description 29
- 102000004196 processed proteins & peptides Human genes 0.000 description 27
- 239000013598 vector Substances 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 23
- 102100025332 Cadherin-9 Human genes 0.000 description 22
- 101710097558 Cadherin-9 Proteins 0.000 description 22
- 229920001184 polypeptide Polymers 0.000 description 22
- 238000013459 approach Methods 0.000 description 21
- 239000003550 marker Substances 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 21
- 230000000295 complement effect Effects 0.000 description 20
- 238000011161 development Methods 0.000 description 20
- 238000003205 genotyping method Methods 0.000 description 20
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 230000018109 developmental process Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 108091034117 Oligonucleotide Proteins 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 230000001537 neural effect Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 108050007957 Cadherin Proteins 0.000 description 11
- 102100022758 Glutamate receptor ionotropic, kainate 2 Human genes 0.000 description 11
- 101000903346 Homo sapiens Glutamate receptor ionotropic, kainate 2 Proteins 0.000 description 11
- 101000903313 Homo sapiens Glutamate receptor ionotropic, kainate 5 Proteins 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 210000004556 brain Anatomy 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 208000035475 disorder Diseases 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 102100024158 Cadherin-10 Human genes 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 101000762229 Homo sapiens Cadherin-10 Proteins 0.000 description 8
- 102100021582 Neurexin-1-beta Human genes 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
- 230000010076 replication Effects 0.000 description 8
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- 102000000905 Cadherin Human genes 0.000 description 7
- 102100040499 Contactin-associated protein-like 2 Human genes 0.000 description 7
- 101000996111 Homo sapiens Neuroligin-4, X-linked Proteins 0.000 description 7
- 241000699660 Mus musculus Species 0.000 description 7
- 102100034441 Neuroligin-4, X-linked Human genes 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000006735 deficit Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 238000011988 family based association test Methods 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000007372 neural signaling Effects 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 238000011830 transgenic mouse model Methods 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 101001108436 Homo sapiens Neurexin-1 Proteins 0.000 description 6
- 101001108433 Homo sapiens Neurexin-1-beta Proteins 0.000 description 6
- 238000003491 array Methods 0.000 description 6
- 238000012093 association test Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 230000008506 pathogenesis Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000009870 specific binding Effects 0.000 description 6
- 229940124597 therapeutic agent Drugs 0.000 description 6
- 102100036364 Cadherin-2 Human genes 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 101000714537 Homo sapiens Cadherin-2 Proteins 0.000 description 5
- 101000749877 Homo sapiens Contactin-associated protein-like 2 Proteins 0.000 description 5
- 101000603172 Homo sapiens Neuroligin-3 Proteins 0.000 description 5
- 108091029795 Intergenic region Proteins 0.000 description 5
- -1 NRXJ N Proteins 0.000 description 5
- 102100038940 Neuroligin-3 Human genes 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 230000006854 communication Effects 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 102100024340 Contactin-4 Human genes 0.000 description 4
- 241000557626 Corvus corax Species 0.000 description 4
- 241000701022 Cytomegalovirus Species 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 4
- 102100032999 Integrin beta-3 Human genes 0.000 description 4
- 108700011259 MicroRNAs Proteins 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102100038992 Neuroligin-1 Human genes 0.000 description 4
- 108700008625 Reporter Genes Proteins 0.000 description 4
- 102100030681 SH3 and multiple ankyrin repeat domains protein 3 Human genes 0.000 description 4
- 101710101741 SH3 and multiple ankyrin repeat domains protein 3 Proteins 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000019522 cellular metabolic process Effects 0.000 description 4
- 210000003169 central nervous system Anatomy 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000001054 cortical effect Effects 0.000 description 4
- 230000002559 cytogenic effect Effects 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 238000009510 drug design Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000010197 meta-analysis Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- 241000972773 Aulopiformes Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102100022481 Cadherin-22 Human genes 0.000 description 3
- 208000031404 Chromosome Aberrations Diseases 0.000 description 3
- 108010015720 Dopamine beta-Hydroxylase Proteins 0.000 description 3
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102100040667 F-box only protein 33 Human genes 0.000 description 3
- 108091007098 FBXO33 Proteins 0.000 description 3
- 102000017707 GABRB3 Human genes 0.000 description 3
- 101000899455 Homo sapiens Cadherin-22 Proteins 0.000 description 3
- 101000909504 Homo sapiens Contactin-4 Proteins 0.000 description 3
- 101001073597 Homo sapiens Gamma-aminobutyric acid receptor subunit beta-3 Proteins 0.000 description 3
- 101001033173 Homo sapiens Methyltransferase-like protein 22 Proteins 0.000 description 3
- 101000603239 Homo sapiens Neuroligin-1 Proteins 0.000 description 3
- 101000982057 Homo sapiens Unconventional myosin-XVI Proteins 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- 102100038290 Methyltransferase-like protein 22 Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000012202 Pervasive developmental disease Diseases 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 102100026677 Unconventional myosin-XVI Human genes 0.000 description 3
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 230000001364 causal effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 210000005153 frontal cortex Anatomy 0.000 description 3
- 208000016361 genetic disease Diseases 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 239000013610 patient sample Substances 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000003765 sex chromosome Anatomy 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000013517 stratification Methods 0.000 description 3
- 210000000225 synapse Anatomy 0.000 description 3
- 230000000946 synaptic effect Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 230000001755 vocal effect Effects 0.000 description 3
- 238000002424 x-ray crystallography Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- RFBVBRVVOPAAFS-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one Chemical compound C1CC2CCN1C(CO)(CO)C2=O RFBVBRVVOPAAFS-UHFFFAOYSA-N 0.000 description 2
- 102100033639 Acetylcholinesterase Human genes 0.000 description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 description 2
- 101800000263 Acidic protein Proteins 0.000 description 2
- 102100035553 Autism susceptibility gene 2 protein Human genes 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- 101710196887 Cadherin-10 Proteins 0.000 description 2
- 102100024156 Cadherin-12 Human genes 0.000 description 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- 101710168458 Contactin-associated protein-like 2 Proteins 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 201000010374 Down Syndrome Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 108091060211 Expressed sequence tag Proteins 0.000 description 2
- 208000001914 Fragile X syndrome Diseases 0.000 description 2
- 102100030540 Gap junction alpha-5 protein Human genes 0.000 description 2
- 102100022193 Glutamate receptor ionotropic, delta-1 Human genes 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101000874361 Homo sapiens Autism susceptibility gene 2 protein Proteins 0.000 description 2
- 101000762238 Homo sapiens Cadherin-12 Proteins 0.000 description 2
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 2
- 101000726548 Homo sapiens Gap junction alpha-5 protein Proteins 0.000 description 2
- 101000900493 Homo sapiens Glutamate receptor ionotropic, delta-1 Proteins 0.000 description 2
- 101000619663 Homo sapiens Leucine-rich repeat-containing protein 1 Proteins 0.000 description 2
- 101001052076 Homo sapiens Maltase-glucoamylase Proteins 0.000 description 2
- 101000741879 Homo sapiens POTE ankyrin domain family member A Proteins 0.000 description 2
- 101000735377 Homo sapiens Protocadherin-7 Proteins 0.000 description 2
- 101000825253 Homo sapiens Sperm protein associated with the nucleus on the X chromosome A Proteins 0.000 description 2
- 101000892344 Homo sapiens Transmembrane protein 185A Proteins 0.000 description 2
- 101000841325 Homo sapiens Urotensin-2 Proteins 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 102100022237 Leucine-rich repeat-containing protein 1 Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 101100298534 Mus musculus Prnp gene Proteins 0.000 description 2
- 101710203761 Neurexin-1 Proteins 0.000 description 2
- 102000005608 Neuronal Cell Adhesion Molecules Human genes 0.000 description 2
- 108010059604 Neuronal Cell Adhesion Molecules Proteins 0.000 description 2
- 102100038749 POTE ankyrin domain family member A Human genes 0.000 description 2
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 2
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 2
- 108010019674 Proto-Oncogene Proteins c-sis Proteins 0.000 description 2
- 102100034941 Protocadherin-7 Human genes 0.000 description 2
- 208000006289 Rett Syndrome Diseases 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 102100022327 Sperm protein associated with the nucleus on the X chromosome A Human genes 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 102100040666 Transmembrane protein 185A Human genes 0.000 description 2
- 208000037280 Trisomy Diseases 0.000 description 2
- 206010044688 Trisomy 21 Diseases 0.000 description 2
- 102100029097 Urotensin-2 Human genes 0.000 description 2
- 210000001766 X chromosome Anatomy 0.000 description 2
- 229940022698 acetylcholinesterase Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000007614 genetic variation Effects 0.000 description 2
- 230000002518 glial effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000003116 impacting effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012750 in vivo screening Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 210000000110 microvilli Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000007838 multiplex ligation-dependent probe amplification Methods 0.000 description 2
- 230000007472 neurodevelopment Effects 0.000 description 2
- 210000004498 neuroglial cell Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000001209 resonance light scattering Methods 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 238000007423 screening assay Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- IPVFGAYTKQKGBM-BYPJNBLXSA-N 1-[(2r,3s,4r,5r)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound F[C@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 IPVFGAYTKQKGBM-BYPJNBLXSA-N 0.000 description 1
- 102100030390 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Human genes 0.000 description 1
- 102100040458 2',3'-cyclic-nucleotide 3'-phosphodiesterase Human genes 0.000 description 1
- 101150055869 25 gene Proteins 0.000 description 1
- 102100038049 5'-AMP-activated protein kinase subunit beta-2 Human genes 0.000 description 1
- 102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 102100034609 Ankyrin repeat domain-containing protein 17 Human genes 0.000 description 1
- 102100036817 Ankyrin-3 Human genes 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 208000036640 Asperger disease Diseases 0.000 description 1
- 201000006062 Asperger syndrome Diseases 0.000 description 1
- 102100027705 Astrotactin-2 Human genes 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 1
- 102100029844 B box and SPRY domain-containing protein Human genes 0.000 description 1
- 102100032481 B-cell CLL/lymphoma 9 protein Human genes 0.000 description 1
- 102100035901 BICD family-like cargo adapter 1 Human genes 0.000 description 1
- 102000015347 COP1 Human genes 0.000 description 1
- 108060001826 COP1 Proteins 0.000 description 1
- 102100027674 CTD small phosphatase-like protein Human genes 0.000 description 1
- 102100024155 Cadherin-11 Human genes 0.000 description 1
- 102100024154 Cadherin-13 Human genes 0.000 description 1
- 102100022529 Cadherin-19 Human genes 0.000 description 1
- 102100025331 Cadherin-8 Human genes 0.000 description 1
- 102100031239 Chromodomain-helicase-DNA-binding protein 1-like Human genes 0.000 description 1
- 102100038164 Chromodomain-helicase-DNA-binding protein 9 Human genes 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 102100031552 Coactosin-like protein Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 101710107714 Contactin-4 Proteins 0.000 description 1
- 102100040495 Contactin-associated protein-like 5 Human genes 0.000 description 1
- 102100027475 Cytochrome c oxidase assembly protein COX18, mitochondrial Human genes 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 102100024352 Dedicator of cytokinesis protein 4 Human genes 0.000 description 1
- FHZPGIUBXYVUOY-VWGYHWLBSA-N Dermorphin Chemical compound C([C@H](N)C(=O)N[C@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)C1=CC=C(O)C=C1 FHZPGIUBXYVUOY-VWGYHWLBSA-N 0.000 description 1
- 101800002242 Dermorphin Proteins 0.000 description 1
- 208000035976 Developmental Disabilities Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 102100024099 Disks large homolog 1 Human genes 0.000 description 1
- 102100031250 Disks large-associated protein 1 Human genes 0.000 description 1
- 102100035372 DmX-like protein 1 Human genes 0.000 description 1
- 101100084900 Drosophila melanogaster Rpn11 gene Proteins 0.000 description 1
- 108010069091 Dystrophin Proteins 0.000 description 1
- 102000001039 Dystrophin Human genes 0.000 description 1
- 102100022207 E3 ubiquitin-protein ligase parkin Human genes 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102100026082 F-box only protein 40 Human genes 0.000 description 1
- 102100026167 Fez family zinc finger protein 2 Human genes 0.000 description 1
- 102100035047 Flavin-containing monooxygenase 5 Human genes 0.000 description 1
- 102100028875 Formylglycine-generating enzyme Human genes 0.000 description 1
- 108010032606 Fragile X Mental Retardation Protein Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010001515 Galectin 4 Proteins 0.000 description 1
- 102100039556 Galectin-4 Human genes 0.000 description 1
- 102100021021 Golgin subfamily A member 6-like protein 2 Human genes 0.000 description 1
- 102100041033 Golgin subfamily B member 1 Human genes 0.000 description 1
- 102100028484 HEAT repeat-containing protein 5B Human genes 0.000 description 1
- 102100034684 Haloacid dehalogenase-like hydrolase domain-containing protein 3 Human genes 0.000 description 1
- 102100040414 Heat shock transcription factor, X-linked Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000583063 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 Proteins 0.000 description 1
- 101000742799 Homo sapiens 5'-AMP-activated protein kinase subunit beta-2 Proteins 0.000 description 1
- 101000986621 Homo sapiens ATP-binding cassette sub-family C member 6 Proteins 0.000 description 1
- 101000924481 Homo sapiens Ankyrin repeat domain-containing protein 17 Proteins 0.000 description 1
- 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 description 1
- 101000936743 Homo sapiens Astrotactin-2 Proteins 0.000 description 1
- 101000864323 Homo sapiens B box and SPRY domain-containing protein Proteins 0.000 description 1
- 101000798495 Homo sapiens B-cell CLL/lymphoma 9 protein Proteins 0.000 description 1
- 101000873626 Homo sapiens BICD family-like cargo adapter 1 Proteins 0.000 description 1
- 101000725950 Homo sapiens CTD small phosphatase-like protein Proteins 0.000 description 1
- 101000762236 Homo sapiens Cadherin-11 Proteins 0.000 description 1
- 101000762243 Homo sapiens Cadherin-13 Proteins 0.000 description 1
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 description 1
- 101000935095 Homo sapiens Cadherin-8 Proteins 0.000 description 1
- 101000882994 Homo sapiens Carbohydrate sulfotransferase 5 Proteins 0.000 description 1
- 101000777053 Homo sapiens Chromodomain-helicase-DNA-binding protein 1-like Proteins 0.000 description 1
- 101000883548 Homo sapiens Chromodomain-helicase-DNA-binding protein 9 Proteins 0.000 description 1
- 101000940352 Homo sapiens Coactosin-like protein Proteins 0.000 description 1
- 101000749883 Homo sapiens Contactin-associated protein-like 5 Proteins 0.000 description 1
- 101000725462 Homo sapiens Cytochrome c oxidase assembly protein COX18, mitochondrial Proteins 0.000 description 1
- 101001052955 Homo sapiens Dedicator of cytokinesis protein 4 Proteins 0.000 description 1
- 101001053984 Homo sapiens Disks large homolog 1 Proteins 0.000 description 1
- 101000844784 Homo sapiens Disks large-associated protein 1 Proteins 0.000 description 1
- 101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 description 1
- 101000804531 Homo sapiens DmX-like protein 1 Proteins 0.000 description 1
- 101000913308 Homo sapiens F-box only protein 40 Proteins 0.000 description 1
- 101000912440 Homo sapiens Fez family zinc finger protein 2 Proteins 0.000 description 1
- 101001022794 Homo sapiens Flavin-containing monooxygenase 5 Proteins 0.000 description 1
- 101000648611 Homo sapiens Formylglycine-generating enzyme Proteins 0.000 description 1
- 101001075380 Homo sapiens Golgin subfamily A member 6-like protein 2 Proteins 0.000 description 1
- 101001039321 Homo sapiens Golgin subfamily B member 1 Proteins 0.000 description 1
- 101000839975 Homo sapiens HEAT repeat-containing protein 5B Proteins 0.000 description 1
- 101000872853 Homo sapiens Haloacid dehalogenase-like hydrolase domain-containing protein 3 Proteins 0.000 description 1
- 101001037907 Homo sapiens Heat shock transcription factor, X-linked Proteins 0.000 description 1
- 101001037204 Homo sapiens Hydrocephalus-inducing protein homolog Proteins 0.000 description 1
- 101001011421 Homo sapiens IQ domain-containing protein E Proteins 0.000 description 1
- 101001134447 Homo sapiens Inactive pancreatic lipase-related protein 1 Proteins 0.000 description 1
- 101001056469 Homo sapiens Keratin, type II cytoskeletal 3 Proteins 0.000 description 1
- 101100181431 Homo sapiens LCE3D gene Proteins 0.000 description 1
- 101100181432 Homo sapiens LCE3E gene Proteins 0.000 description 1
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 description 1
- 101000620894 Homo sapiens Lysophosphatidic acid phosphatase type 6 Proteins 0.000 description 1
- 101001038491 Homo sapiens Lysozyme g-like protein 2 Proteins 0.000 description 1
- 101000969961 Homo sapiens Neurexin-3 Proteins 0.000 description 1
- 101000969963 Homo sapiens Neurexin-3-beta Proteins 0.000 description 1
- 101000634529 Homo sapiens Nuclear pore-associated protein 1 Proteins 0.000 description 1
- 101001130823 Homo sapiens Oxysterol-binding protein-related protein 10 Proteins 0.000 description 1
- 101000986765 Homo sapiens Oxytocin receptor Proteins 0.000 description 1
- 101001009074 Homo sapiens Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Proteins 0.000 description 1
- 101000808590 Homo sapiens Probable ubiquitin carboxyl-terminal hydrolase FAF-Y Proteins 0.000 description 1
- 101000619617 Homo sapiens Proline-rich membrane anchor 1 Proteins 0.000 description 1
- 101000946275 Homo sapiens Protein CLEC16A Proteins 0.000 description 1
- 101001051777 Homo sapiens Protein kinase C alpha type Proteins 0.000 description 1
- 101000601855 Homo sapiens Protocadherin-1 Proteins 0.000 description 1
- 101001035676 Homo sapiens Pseudouridine-5'-phosphatase Proteins 0.000 description 1
- 101000825960 Homo sapiens R-spondin-3 Proteins 0.000 description 1
- 101001076721 Homo sapiens RNA-binding protein 38 Proteins 0.000 description 1
- 101000742932 Homo sapiens Retinol dehydrogenase 16 Proteins 0.000 description 1
- 101000825912 Homo sapiens SAYSvFN domain-containing protein 1 Proteins 0.000 description 1
- 101000663831 Homo sapiens SH3 and PX domain-containing protein 2A Proteins 0.000 description 1
- 101000703464 Homo sapiens SH3 and multiple ankyrin repeat domains protein 2 Proteins 0.000 description 1
- 101000864837 Homo sapiens SIN3-HDAC complex-associated factor Proteins 0.000 description 1
- 101000851696 Homo sapiens Steroid hormone receptor ERR2 Proteins 0.000 description 1
- 101000839323 Homo sapiens Synaptotagmin-7 Proteins 0.000 description 1
- 101000852716 Homo sapiens T-cell immunomodulatory protein Proteins 0.000 description 1
- 101000831834 Homo sapiens Transmembrane protein 231 Proteins 0.000 description 1
- 101000764644 Homo sapiens Trimethyllysine dioxygenase, mitochondrial Proteins 0.000 description 1
- 101000800807 Homo sapiens Tumor necrosis factor alpha-induced protein 8 Proteins 0.000 description 1
- 101000744939 Homo sapiens Zinc finger protein 492 Proteins 0.000 description 1
- 101000723601 Homo sapiens Zinc finger protein 528 Proteins 0.000 description 1
- 101000723613 Homo sapiens Zinc finger protein 534 Proteins 0.000 description 1
- 101000743802 Homo sapiens Zinc finger protein 675 Proteins 0.000 description 1
- 101000743810 Homo sapiens Zinc finger protein 681 Proteins 0.000 description 1
- 101000772560 Homo sapiens Zinc finger transcription factor Trps1 Proteins 0.000 description 1
- 101000978006 Homo sapiens cAMP-dependent protein kinase inhibitor beta Proteins 0.000 description 1
- 102100040204 Hydrocephalus-inducing protein homolog Human genes 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 102100029840 IQ domain-containing protein E Human genes 0.000 description 1
- 102100033358 Inactive pancreatic lipase-related protein 1 Human genes 0.000 description 1
- 102000006541 Ionotropic Glutamate Receptors Human genes 0.000 description 1
- 108010008812 Ionotropic Glutamate Receptors Proteins 0.000 description 1
- 102100025759 Keratin, type II cytoskeletal 3 Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 229930195714 L-glutamate Natural products 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 102100024572 Late cornified envelope protein 3D Human genes 0.000 description 1
- 102100024575 Late cornified envelope protein 3E Human genes 0.000 description 1
- 241001487991 Lettuce chlorosis virus Species 0.000 description 1
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 description 1
- 102100022916 Lysophosphatidic acid phosphatase type 6 Human genes 0.000 description 1
- 102100040286 Lysozyme g-like protein 2 Human genes 0.000 description 1
- 101700028140 MYO1D Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 1
- 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 101150118742 NP gene Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 102100021310 Neurexin-3 Human genes 0.000 description 1
- 208000029726 Neurodevelopmental disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 102100029048 Nuclear pore-associated protein 1 Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102100031469 Oxysterol-binding protein-related protein 10 Human genes 0.000 description 1
- 102100028139 Oxytocin receptor Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
- 101710133394 POU domain, class 3, transcription factor 2 Proteins 0.000 description 1
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 101710182846 Polyhedrin Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102100027376 Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102100038600 Probable ubiquitin carboxyl-terminal hydrolase FAF-Y Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102100022184 Proline-rich membrane anchor 1 Human genes 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 102100034718 Protein CLEC16A Human genes 0.000 description 1
- 102100024924 Protein kinase C alpha type Human genes 0.000 description 1
- 102100037551 Protocadherin-1 Human genes 0.000 description 1
- 102100036386 Protocadherin-10 Human genes 0.000 description 1
- 101710158923 Protocadherin-10 Proteins 0.000 description 1
- 108700040559 Protocadherins Proteins 0.000 description 1
- 102100039391 Pseudouridine-5'-phosphatase Human genes 0.000 description 1
- 102100022766 R-spondin-3 Human genes 0.000 description 1
- 102100025859 RNA-binding protein 38 Human genes 0.000 description 1
- 208000033639 Rare pervasive developmental disease Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102100021289 Regulator of G-protein signaling 20 Human genes 0.000 description 1
- 101710148117 Regulator of G-protein signaling 20 Proteins 0.000 description 1
- 102100038057 Retinol dehydrogenase 16 Human genes 0.000 description 1
- 241000714474 Rous sarcoma virus Species 0.000 description 1
- 102100022776 SAYSvFN domain-containing protein 1 Human genes 0.000 description 1
- 102100038875 SH3 and PX domain-containing protein 2A Human genes 0.000 description 1
- 102100030680 SH3 and multiple ankyrin repeat domains protein 2 Human genes 0.000 description 1
- 102100030066 SIN3-HDAC complex-associated factor Human genes 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- 108091027967 Small hairpin RNA Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 102100036831 Steroid hormone receptor ERR2 Human genes 0.000 description 1
- 102100023532 Synaptic functional regulator FMR1 Human genes 0.000 description 1
- 102100028197 Synaptotagmin-7 Human genes 0.000 description 1
- 102100036378 T-cell immunomodulatory protein Human genes 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 102100024183 Transmembrane protein 231 Human genes 0.000 description 1
- 102100026223 Trimethyllysine dioxygenase, mitochondrial Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100033649 Tumor necrosis factor alpha-induced protein 8 Human genes 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102000018390 Ubiquitin-Specific Proteases Human genes 0.000 description 1
- 108010066496 Ubiquitin-Specific Proteases Proteins 0.000 description 1
- 102100036638 Unconventional myosin-Id Human genes 0.000 description 1
- 206010049644 Williams syndrome Diseases 0.000 description 1
- 108700029631 X-Linked Genes Proteins 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- 102100039969 Zinc finger protein 492 Human genes 0.000 description 1
- 102100027803 Zinc finger protein 528 Human genes 0.000 description 1
- 102100027859 Zinc finger protein 534 Human genes 0.000 description 1
- 102100039039 Zinc finger protein 675 Human genes 0.000 description 1
- 102100039053 Zinc finger protein 681 Human genes 0.000 description 1
- 102100030619 Zinc finger transcription factor Trps1 Human genes 0.000 description 1
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000012443 analytical study Methods 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 102100023516 cAMP-dependent protein kinase inhibitor beta Human genes 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 230000017484 calcium-dependent cell-cell adhesion Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000023402 cell communication Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000008711 chromosomal rearrangement Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- YUZILKLGVPUFOT-YHPRVSEPSA-L disodium;5-[(6-anilino-4-oxo-1h-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(6-anilino-4-oxo-1h-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].C=1C=C(\C=C\C=2C(=CC(NC=3NC(NC=4C=CC=CC=4)=NC(=O)N=3)=CC=2)S([O-])(=O)=O)C(S(=O)(=O)[O-])=CC=1NC(N1)=NC(=O)N=C1NC1=CC=CC=C1 YUZILKLGVPUFOT-YHPRVSEPSA-L 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000007878 drug screening assay Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 102000054766 genetic haplotypes Human genes 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- 210000002980 germ line cell Anatomy 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 239000004030 hiv protease inhibitor Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000005497 microtitration Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 108090001100 neuroligin 1 Proteins 0.000 description 1
- 210000000715 neuromuscular junction Anatomy 0.000 description 1
- 230000023362 neuron cell-cell adhesion Effects 0.000 description 1
- 230000005015 neuronal process Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 102000045222 parkin Human genes 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000012107 replication analysis Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000013515 script Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002924 silencing RNA Substances 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 230000011273 social behavior Effects 0.000 description 1
- 230000003997 social interaction Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000008184 synaptic development Effects 0.000 description 1
- 230000003956 synaptic plasticity Effects 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 210000002504 synaptic vesicle Anatomy 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 101150061422 yip5 gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3013608P | 2008-02-20 | 2008-02-20 | |
| US61/030,136 | 2008-02-20 | ||
| US10716308P | 2008-10-21 | 2008-10-21 | |
| US61/107,163 | 2008-10-21 | ||
| PCT/US2009/034784 WO2009105718A1 (en) | 2008-02-20 | 2009-02-20 | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatmemt of autism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2009217278A1 AU2009217278A1 (en) | 2009-08-27 |
| AU2009217278B2 true AU2009217278B2 (en) | 2015-08-20 |
Family
ID=40985948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009217278A Ceased AU2009217278B2 (en) | 2008-02-20 | 2009-02-20 | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9783851B2 (enExample) |
| EP (1) | EP2257644B1 (enExample) |
| JP (1) | JP6078211B2 (enExample) |
| AU (1) | AU2009217278B2 (enExample) |
| CA (1) | CA2716375C (enExample) |
| WO (1) | WO2009105718A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101769999B1 (ko) | 2008-09-18 | 2017-08-21 | 노오쓰웨스턴 유니버시티 | Ｎｍｄａ 수용체 조절제 및 그의 용도 |
| US20100210471A1 (en) * | 2008-11-12 | 2010-08-19 | University Of Utah Research Foundation | Autism associated genetic markers |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| EP2493471B1 (en) * | 2009-10-26 | 2019-11-27 | Thomas Julius Borody | Novel enteric combination therapy |
| ES2686300T3 (es) | 2010-08-24 | 2018-10-17 | The Children's Hospital Of Philadelphia | Asociación de variaciones genéticas raras recurrentes con el trastorno por déficit de atención e hiperactividad (TDAH) y procedimientos de uso de las mismas para el diagnóstico y tratamiento del mismo |
| US20140107037A1 (en) * | 2011-04-27 | 2014-04-17 | Northwestern University | Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders |
| WO2012173809A2 (en) * | 2011-06-02 | 2012-12-20 | Ehli Erik | Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders |
| CA2798906A1 (en) * | 2011-12-22 | 2013-06-22 | Mohammed Uddin | Genome-wide detection of genomic rearrangements and use of genomic rearrangements to diagnose genetic disease |
| US20130210657A1 (en) * | 2012-01-25 | 2013-08-15 | The Hospital For Sick Children | Method of Determining Risk of Autism Spectrum Disorder |
| KR20140140069A (ko) * | 2012-03-05 | 2014-12-08 | 버그 엘엘씨 | 전반적 발달장애의 진단 및 치료용 조성물 및 그 진단 및 치료 방법 |
| AU2013229381A1 (en) * | 2012-03-09 | 2014-09-25 | Integragen | A genotyping test for assessing risk of autism |
| WO2013139861A1 (en) | 2012-03-20 | 2013-09-26 | Luc Montagnier | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
| JP6189926B2 (ja) | 2012-04-02 | 2017-08-30 | バーグ エルエルシー | 照合による細胞に基づくアッセイ及びその使用 |
| WO2014012144A1 (en) * | 2012-07-20 | 2014-01-23 | The University Of Melbourne | Method of diagnosing or prognosing a neurological disorder |
| CN105308049A (zh) | 2013-01-29 | 2016-02-03 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| WO2014120786A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| SI2951183T1 (sl) | 2013-01-29 | 2019-07-31 | Aptinyx Inc. | Spiro-laktam NMDA receptorski modulatorji in njihove uporabe |
| WO2014120784A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| US9738650B2 (en) | 2013-01-29 | 2017-08-22 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
| AU2015314956A1 (en) | 2014-09-11 | 2017-04-06 | Berg Llc | Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data |
| WO2016057810A1 (en) * | 2014-10-08 | 2016-04-14 | The Broad Institute, Inc. | Markers for assessing risk of developing or having obsessive compulsive disorder |
| US20170369945A1 (en) * | 2014-12-29 | 2017-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of diagnosing autism spectrum disorders |
| AU2016318780B2 (en) | 2015-09-08 | 2022-04-07 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating Tourette syndrome |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| WO2017201283A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| JP7032378B2 (ja) | 2016-08-01 | 2022-03-08 | アプティニックス インコーポレイテッド | スピロ－ラクタムｎｍｄａ受容体修飾因子及びその使用 |
| SG11201900554YA (en) | 2016-08-01 | 2019-02-27 | Aptinyx Inc | Spiro-lactam nmda modulators and methods of using same |
| MX383650B (es) | 2016-08-01 | 2025-03-14 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactam y uso de los mismos. |
| WO2018026763A1 (en) | 2016-08-01 | 2018-02-08 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| AU2017306158B2 (en) | 2016-08-01 | 2021-10-14 | Aptinyx Inc. | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof |
| CN112204031B (zh) | 2018-01-31 | 2024-05-24 | 元羿生物科技(香港)有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060194201A1 (en) * | 2002-10-10 | 2006-08-31 | Jean-Pierre Fryns | Autism gene |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071314B2 (en) * | 2001-12-14 | 2011-12-06 | President And Fellows Of Harvard College | Immunocellular receptors related to neurological disorders and therapeutic uses thereof |
-
2009
- 2009-02-20 CA CA2716375A patent/CA2716375C/en active Active
- 2009-02-20 EP EP09713119.7A patent/EP2257644B1/en active Active
- 2009-02-20 AU AU2009217278A patent/AU2009217278B2/en not_active Ceased
- 2009-02-20 JP JP2010547822A patent/JP6078211B2/ja not_active Expired - Fee Related
- 2009-02-20 US US12/918,508 patent/US9783851B2/en active Active
- 2009-02-20 WO PCT/US2009/034784 patent/WO2009105718A1/en not_active Ceased
-
2017
- 2017-10-09 US US15/727,868 patent/US20180148786A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060194201A1 (en) * | 2002-10-10 | 2006-08-31 | Jean-Pierre Fryns | Autism gene |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2716375A1 (en) | 2009-08-27 |
| EP2257644A1 (en) | 2010-12-08 |
| US9783851B2 (en) | 2017-10-10 |
| AU2009217278A1 (en) | 2009-08-27 |
| US20110207124A1 (en) | 2011-08-25 |
| US20180148786A1 (en) | 2018-05-31 |
| JP6078211B2 (ja) | 2017-02-15 |
| CA2716375C (en) | 2018-05-29 |
| WO2009105718A1 (en) | 2009-08-27 |
| EP2257644B1 (en) | 2015-06-24 |
| JP2011512163A (ja) | 2011-04-21 |
| EP2257644A4 (en) | 2011-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009217278B2 (en) | Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism | |
| AU2017201900B2 (en) | Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same | |
| US20150051114A1 (en) | Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets | |
| US20140315992A1 (en) | Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism | |
| US20230304094A1 (en) | Genomic alterations associated with schizophrenia and methods of use thereof for the diagnosis and treatment of the same | |
| WO2012037116A2 (en) | Common and rare genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof for the treatment and diagnosis of the same | |
| EP3149211A1 (en) | Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism | |
| WO2021050608A1 (en) | Novel genetic markers for postural orthostatic tachycardia syndrome (pots) and methods of use thereof for diagnosis and treatment of the same | |
| US20230357849A1 (en) | Genetic alterations associated with eosinophilic esophagitis and methods of use thereof for the diagnosis and treatment of disease | |
| WO2013142286A1 (en) | Genetic alterations associated with autism and the autistic phenotype in the israeli population and methods of use thereof for the diagnosis and treatment of autism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ GENETIC ALTERATIONS ASSOCIATED WITH AUTISM AND THE AUTISTIC PHENOTYPE AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF AUTISM |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |